HemaPrime™ COVID-19 Products, Vaccinated Samples (Time Series)

Supplier: Charles River Laboratories Cell Solutions
HemaPrime™
COV-VAC-MNC-1150M COV-VAC-SRM-1151M COV-VAC-SRM-1151P COV-VAC-MNC-1150P COV-VAC-PLS-1152M COV-VAC-PLS-1152P
77529-702EA 2085.75 USD
77529-702 77529-704 77575-074 77529-696 77529-698 77529-700
HemaPrime™ COVID-19 Products, Vaccinated Samples (Time Series)
Blood
Peripheral blood cells are collected from healthy donors by direct collection or by using the Spectra Optia® Apheresis system. Cell-rich leukapheresis product is extracted using continuous flow centrifugal technology directly into the collection bag.

Purification, isolation, and cryopreservation of cells are performed on-site immediately following collection utilizing best-in-class instruments, biopreservation media, and standardized protocols. The rigorous operational controls mitigate any potential loss while ensuring viable and functional cells post-thaw, guaranteeing that customers receive consistent high-quality cells.

COVID-19 Products: This COVID-19-related product portfolio includes COVID-19 vaccinated times series PBMCs, plasma, and serum, in addition to convalescent plasma and serum. COVID-19 vaccinated time series products include matched peripheral blood mononuclear cells (PBMCs), serum, and plasma that are collected at specific timepoints from healthy donors, with no prior COVID-19 infection and who have received a COVID-19 vaccine. These time series samples are collected prior to COVID-19 vaccination, 10 to 30 days after the first vaccine administration, and 10 to 30 days after the second vaccine administration (when applicable).

Delivery information: Dry ice or liquid nitrogen dewar.

Packaging: 1 ml cryovial.

Caution: For research use only.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR